Evidence shows that a gradual tapering process minimizes withdrawal symptoms and supports a smoother transition off treatment
FDA Prescribing Information for Semaglutide (Ozempic) FDA Prescribing Information for Tirzepatide (Mounjaro) Trujillo, J
Your prescribing provider may reduce or adjust doses of these agents to prevent dangerously low blood sugar episodes
My crystal ball guess would be a thumbs up for cagrilintide, and a more uncertain outlook for a GIP-Semaglutide combination #diabetes @novonordiskAs we celebrate #insulin100 lets not forget innovation #insulin with glucose-sensitive insulins and once weekly insulin icodec the leading candidates @novonordisk Which one might be a "gamechanger"
Patients prescribed Wegovy should understand their rights and responsibilities regarding medical information in employment contexts
Cardiovascular safety was demonstrated in the ORIGIN (glargine)56 and DEVOTE (degludec) trials.57 Basal insulin analogs (glargine U100 and U300, detemir, degludec) have shown a lesser risk of hypoglycemia (particularly nocturnal hypoglycemia) than human NPH insulin.58 The cost of such treatment is higher, and insulin degludec is the most expensive, its prescription within the public healthcare system currently being limited to authorized cases only